Oligodendrocyte precursor cells and methods of obtaining and culturing the same

Details for Australian Patent Application No. 2004257000 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Okazaki, Hiroshi

Agent Davies Collison Cave

Pub. Number AU-B-2004257000

PCT Pub. Number WO2005/007797

Priority 60/487,933 18.07.03 US

Filing date 19 July 2004

Wipo publication date 27 January 2005

Acceptance publication date 21 July 2011

International Classifications

C12N 5/079 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Neural cells

C12N 5/0797 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Stem cells

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

Event Publications

2 March 2006 PCT application entered the National Phase

  PCT publication WO2005/007797 Priority application(s): WO2005/007797

21 July 2011 Application Accepted

  Published as AU-B-2004257000

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004257011-Combretastatin derivatives with cytotoxic action

2004256994-Improved process for preparing alphapolymorphic eletriptan hydrobromide